Loading…
Boston Scientific agreed to acquire Silk Road Medical, a medical device company focused on stroke prevention via the TCAR procedure, for $27.50 per share, enterprise value of approximately $1.16 billion.
“The TCAR platform developed by Silk Road Medical is a notable advancement in the field of vascular medicine”news.bostonscientific.com
Summarized from public sources; check the original articles before acting on it.